{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:33:06Z","timestamp":1788139986793,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022jj30345"],"award-info":[{"award-number":["2022jj30345"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13258-025-01669-0","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T10:04:00Z","timestamp":1755684240000},"page":"983-996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting the miR-325-3p\/GSTP1 axis overcomes paclitaxel resistance in triple-negative breast cancer by inducing ferroptosis"],"prefix":"10.1007","volume":"47","author":[{"given":"Huiling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"1669_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ejso.2007.07.008","volume":"34","author":"T Arai","year":"2008","unstructured":"Arai T, Miyoshi Y, Kim SJ, Akazawa K, Maruyama N, Taguchi T, Tamaki Y, Noguchi S (2008) Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers. Eur J Surg Oncol 34:734\u2013738. https:\/\/doi.org\/10.1016\/j.ejso.2007.07.008","journal-title":"Eur J Surg Oncol"},{"key":"1669_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5","journal-title":"Cell"},{"key":"1669_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674\u2013690. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66","journal-title":"Nat Rev Clin Oncol"},{"key":"1669_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"1669_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","volume":"60","author":"R Garzon","year":"2009","unstructured":"Garzon R, Calin GA, Croce CM (2009) Micrornas in cancer. Annu Rev Med 60:167\u2013179. https:\/\/doi.org\/10.1146\/annurev.med.59.053006.104707","journal-title":"Annu Rev Med"},{"key":"1669_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102822","volume":"65","author":"Y He","year":"2023","unstructured":"He Y, Ling Y, Zhang Z, Mertens RT, Cao Q, Xu X, Guo K, Shi Q, Zhang X, Huo L et al (2023) Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression. Redox Biol 65:102822. https:\/\/doi.org\/10.1016\/j.redox.2023.102822","journal-title":"Redox Biol"},{"key":"1669_CR7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1158\/0008-5472.Can-22-1999","volume":"83","author":"Q Hu","year":"2023","unstructured":"Hu Q, Dai J, Zhang Z, Yu H, Zhang J, Zhu X, Qin Y, Zhang L, Zhang P (2023) ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells. Cancer Res 83:1646\u20131665. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1999","journal-title":"Cancer Res"},{"key":"1669_CR8","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/carcin\/bgs140","volume":"33","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM (2012) Microrna involvement in human cancer. Carcinogenesis 33:1126\u20131133. https:\/\/doi.org\/10.1093\/carcin\/bgs140","journal-title":"Carcinogenesis"},{"key":"1669_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B (2022) Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 22:381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0","journal-title":"Nat Rev Cancer"},{"key":"1669_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12967-021-02978-0","volume":"19","author":"X Lei","year":"2021","unstructured":"Lei X, Du L, Yu W, Wang Y, Ma N, Qu B (2021) GSTP1 as a novel target in radiation induced lung injury. J Transl Med 19:297. https:\/\/doi.org\/10.1186\/s12967-021-02978-0","journal-title":"J Transl Med"},{"key":"1669_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bbrc.2019.08.116","volume":"519","author":"R Li","year":"2019","unstructured":"Li R, Xu T, Wang H, Wu N, Liu F, Jia X, Mi J, Lv J, Gao H (2019) Dysregulation of the miR-325-3p\/DPAGT1 axis supports HBV-positive HCC chemoresistance. Biochem Biophys Res Commun 519:358\u2013365. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.116","journal-title":"Biochem Biophys Res Commun"},{"key":"1669_CR12","doi-asserted-by":"publisher","first-page":"9303","DOI":"10.26355\/eurrev_202009_23012","volume":"24","author":"R Li","year":"2020","unstructured":"Li R, Zheng JZ, Huang X (2020) Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis. Eur Rev Med Pharmacol Sci 24:9303\u20139314. https:\/\/doi.org\/10.26355\/eurrev_202009_23012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1669_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/0008-5472.Can-22-2709","volume":"83","author":"L Liao","year":"2023","unstructured":"Liao L, Zhang YL, Deng L, Chen C, Ma XY, Andriani L, Yang SY, Hu SY, Zhang FL, Shao ZM et al (2023) Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer Res 83:471\u2013484. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2709","journal-title":"Cancer Res"},{"key":"1669_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1517\/14740338.6.5.609","volume":"6","author":"NI Marupudi","year":"2007","unstructured":"Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM, Brem H (2007) Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6:609\u2013621. https:\/\/doi.org\/10.1517\/14740338.6.5.609","journal-title":"Expert Opin Drug Saf"},{"key":"1669_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1349-7006.2012.02231.x","volume":"103","author":"T Miyake","year":"2012","unstructured":"Miyake T, Nakayama T, Naoi Y, Yamamoto N, Otani Y, Kim SJ, Shimazu K, Shimomura A, Maruyama N, Tamaki Y et al (2012) GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci 103:913\u2013920. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02231.x","journal-title":"Cancer Sci"},{"key":"1669_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2023.151548","volume":"40","author":"G Patel","year":"2024","unstructured":"Patel G, Prince A, Harries M (2024) Advanced triple-negative breast cancer. Semin Oncol Nurs 40:151548. https:\/\/doi.org\/10.1016\/j.soncn.2023.151548","journal-title":"Semin Oncol Nurs"},{"key":"1669_CR17","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2023.7","volume":"25","author":"MC Sell","year":"2023","unstructured":"Sell MC, Ramlogan-Steel CA, Steel JC, Dhungel BP (2023) Micrornas in cancer metastasis: biological and therapeutic implications. Expert Rev Mol Med 25:e14. https:\/\/doi.org\/10.1017\/erm.2023.7","journal-title":"Expert Rev Mol Med"},{"key":"1669_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"1669_CR19","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.2147\/ott.S262896","volume":"13","author":"T Sun","year":"2020","unstructured":"Sun T, Li K, Zhu K, Yan R, Dang C, Yuan D (2020) SNHG6 interacted with miR-325-3p to regulate cisplatin resistance of gastric cancer by targeting GITR. Onco Targets Ther 13:12181\u201312193. https:\/\/doi.org\/10.2147\/ott.S262896","journal-title":"Onco Targets Ther"},{"key":"1669_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1102158","volume":"9","author":"X Tan","year":"2022","unstructured":"Tan X, Huang X, Niu B, Guo X, Lei X, Qu B (2022) Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: existing evidence and future directions. Front Mol Biosci 9:1102158. https:\/\/doi.org\/10.3389\/fmolb.2022.1102158","journal-title":"Front Mol Biosci"},{"key":"1669_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205262","volume":"10","author":"SQ Wang","year":"2023","unstructured":"Wang SQ, Chen JJ, Jiang Y, Lei ZN, Ruan YC, Pan Y, Yam JWP, Wong MP, Xiao ZJ (2023a) Targeting GSTP1 as therapeutic strategy against lung adenocarcinoma stemness and resistance to tyrosine kinase inhibitors. Adv Sci (Weinh) 10:e2205262. https:\/\/doi.org\/10.1002\/advs.202205262","journal-title":"Adv Sci (Weinh)"},{"key":"1669_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H (2023b) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 66:100916. https:\/\/doi.org\/10.1016\/j.drup.2022.100916","journal-title":"Drug Resist Updat"},{"key":"1669_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165\u2013176. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014","journal-title":"Trends Cell Biol"},{"issue":"2","key":"1669_CR24","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/j.clbc.2021.06.009","volume":"22","author":"M Yi","year":"2022","unstructured":"Yi M, Peng C, Xia B, Gan L (2022) CXCL8 facilitates the survival and paclitaxel-resistance of triple-negative breast cancers. Clin Breast Cancer 22(2):e191\u2013e198. https:\/\/doi.org\/10.1016\/j.clbc.2021.06.009","journal-title":"Clin Breast Cancer"},{"key":"1669_CR25","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s10620-020-06579-7","volume":"66","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chen H, Song Y, Gu Q, Zhang L, Xie Q, Xu J, Zhang M (2021) MiR-325 promotes oxaliplatin-induced cytotoxicity against colorectal cancer through the HSPA12B\/PI3K\/AKT\/Bcl-2 pathway. Dig Dis Sci 66:2651\u20132660. https:\/\/doi.org\/10.1007\/s10620-020-06579-7","journal-title":"Dig Dis Sci"},{"key":"1669_CR26","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","volume":"83","author":"W Zhang","year":"2023","unstructured":"Zhang W, Dai J, Hou G, Liu H, Zheng S, Wang X, Lin Q, Zhang Y, Lu M, Gong Y et al (2023) SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol Cell 83:4352-4369.e4358. https:\/\/doi.org\/10.1016\/j.molcel.2023.10.042","journal-title":"Mol Cell"},{"issue":"Oct 6","key":"1669_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02196-9","volume":"10","author":"H Zhu","year":"2024","unstructured":"Zhu H, Jiang CW, Zhang WL, Yang ZY, Sun G (2024) Targeting oncogenic MAGEA6 sensitizes triple negative breast cancer to doxorubicin through its autophagy and ferroptosis by stabling AMPK\u03b11. Cell Death Discov 10(Oct 6):430. https:\/\/doi.org\/10.1038\/s41420-024-02196-9","journal-title":"Cell Death Discov"},{"key":"1669_CR28","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.7150\/ijbs.66917","volume":"18","author":"YB Zuo","year":"2022","unstructured":"Zuo YB, Zhang YF, Zhang R, Tian JW, Lv XB, Li R, Li SP, Cheng MD, Shan J, Zhao Z et al (2022) Ferroptosis in cancer progression: role of noncoding RNAs. Int J Biol Sci 18:1829\u20131843. https:\/\/doi.org\/10.7150\/ijbs.66917","journal-title":"Int J Biol Sci"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01669-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-025-01669-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01669-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:02:24Z","timestamp":1760209344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-025-01669-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1669"],"URL":"https:\/\/doi.org\/10.1007\/s13258-025-01669-0","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of Hunan Provincial People\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}